Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Grohmann

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Organic Letters|December 27, 2011
Rh[III]-catalyzed direct C-H amination using N-chloroamines at room temperatureChristoph Grohmann, Honggen Wang, Frank Glorius
Organic Letters|June 4, 2013
Rh[III]-catalyzed C-H amidation using aroyloxycarbamates to give N-Boc protected arylaminesChristoph Grohmann, Honggen Wang, Frank Glorius
Molecular Microbiology|November 24, 2021
Targeted protein degradation at the host-pathogen interfaceChristoph Grohmann, Danushka S Marapana, Gregor Ebert
Journal of the American Chemical Society|February 1, 2011
Rh(III)-catalyzed directed C-H olefination using an oxidizing directing group: mild, efficient, and versatileSouvik Rakshit, Christoph Grohmann, Tatiana Besset, et al.
Journal of the American Chemical Society|November 14, 2012
Mild Rh(III)-catalyzed C-H activation and annulation with alkyne MIDA boronates: short, efficient synthesis of heterocyclic boronic acid derivativesHonggen Wang, Christoph Grohmann, Corinna Nimphius, et al.
Journal of the American Chemical Society|June 10, 2010
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinomaDouglas D Young, Colleen M Connelly, Christoph Grohmann, et al.
ACS Chemical Biology|January 6, 2022
Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate UbiquitinationHao Chen, Yuntong Wu, Kunlun Li, et al.
Redox Biology|December 6, 2022
Design and characterization of a heterobifunctional degrader of KEAP1Hao Chen, Nghi H Nguyen, Charlene M Magtoto, et al.
Nature Communications|May 29, 2026
The benchmarking and application of tag-degraders in vivo to validate therapeutic targetsCharlene M Magtoto, Stephen Mieruszynski, Hao Dong, et al.
The Biochemical Journal|April 28, 2023
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinaseCatia L Pierotti, Annette V Jacobsen, Christoph Grohmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Organic Letters|December 27, 2011
Rh[III]-catalyzed direct C-H amination using N-chloroamines at room temperatureChristoph Grohmann, Honggen Wang, Frank Glorius
Organic Letters|June 4, 2013
Rh[III]-catalyzed C-H amidation using aroyloxycarbamates to give N-Boc protected arylaminesChristoph Grohmann, Honggen Wang, Frank Glorius
Molecular Microbiology|November 24, 2021
Targeted protein degradation at the host-pathogen interfaceChristoph Grohmann, Danushka S Marapana, Gregor Ebert
Journal of the American Chemical Society|February 1, 2011
Rh(III)-catalyzed directed C-H olefination using an oxidizing directing group: mild, efficient, and versatileSouvik Rakshit, Christoph Grohmann, Tatiana Besset, et al.
Journal of the American Chemical Society|November 14, 2012
Mild Rh(III)-catalyzed C-H activation and annulation with alkyne MIDA boronates: short, efficient synthesis of heterocyclic boronic acid derivativesHonggen Wang, Christoph Grohmann, Corinna Nimphius, et al.
Journal of the American Chemical Society|June 10, 2010
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinomaDouglas D Young, Colleen M Connelly, Christoph Grohmann, et al.
ACS Chemical Biology|January 6, 2022
Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate UbiquitinationHao Chen, Yuntong Wu, Kunlun Li, et al.
Redox Biology|December 6, 2022
Design and characterization of a heterobifunctional degrader of KEAP1Hao Chen, Nghi H Nguyen, Charlene M Magtoto, et al.
Nature Communications|May 29, 2026
The benchmarking and application of tag-degraders in vivo to validate therapeutic targetsCharlene M Magtoto, Stephen Mieruszynski, Hao Dong, et al.
The Biochemical Journal|April 28, 2023
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinaseCatia L Pierotti, Annette V Jacobsen, Christoph Grohmann, et al.
Pageof 2